NuVasive, VertiFlex, K2M & more — 12 key notes

Written by Anuja Vaidya | May 29, 2015 | Print  |

Here are 12 key notes on orthopedic and spine device companies over the past week.

ConforMIS filed to raise up to $172.5 million through an initial public offering of common shares.

The first two implantations of Dymicron's Triadyme-C cervical total disc replacement device were successful.


K2M received a new average price target from five analysts covering the company — $26.33.

Isador Lieberman, MD, performed a live surgical procedure using Mazor Robotics' Renaissance system at the Joint Congress of the Chinese Association of Orthopaedic Surgeons and North American Spine Society.


China could be Medtronic PLC's new frontier.


An appeals court is upholding a verdict from earlier this month when a San Diego jury found NuVasive and a local surgeon made false statements about the company's NeuroVision device last year.


NuVasive named Gregory T. Lucier CEO of the company.


NuVasive's new CEO, Gregory T. Lucier, purchased 34,000 company shares in a transaction disclosed on May 28.


The National Association of Professional Women inducted Lisa Ferrara, PhD, CEO of OrthoKinetic Technologies/OrthoKinetic Testing Technologies, into its VIP Woman of the Year Circle.

SI-BONE closed a round of capital growth financing amounting to $21 million.


SI-BONE named Laura Francis chief financial officer.


The FDA issued a pre-market approval order for VertiFlex's Superion Interspinous Spacer System.

More articles on devices:
LESS Institute gets $30M senior credit facility — 5 key notes
Is Smith & Nephew's cost-conscious strategy working? 5 key notes
New NuVasive CEO Gregory Lucier buys 34k shares — 5 key notes

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months